Skip to main content

Table 2 Comparison of outcomes between ET, IMT and LT by grouping criteria II (ET ≤ 7d; 7d < IMT ≤ 14d; LT > 14d)

From: The impact of delayed tracheostomy on critically ill patients receiving mechanical ventilation: a retrospective cohort study in a chinese tertiary hospital

The timing of tracheostomy after intubation

Discharge Status, %

Length of stay, median (IQR)

Time receiving MV, median (IQR)

Death/Poor/Good

In-hospital

ICU

Total

Before TT

After TT

Grouping Criteria II (ET: ≤ 7d, IMT: 7 < d ≤ 14, LT: > 14d)

 Included patients, n = 1884

  ET (n = 838)

1.4 / 10.7 / 87.8

21(16–30)

20(15–28)

8(5–12.25)

5(3–6)

3(1–8)

  IMT (n = 710)

1.5 / 14.9 / 83.5

29(22–41)

27(20–39)

15(11–23)

10(8–12)

4(1–13)

  LT (n = 336)

6.8 / 15.8 / 77.4

43(33–65)

41(31–60.5)

28(20–41)

18(15–23)

9(3–20)

  P-value

 < 0.05

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 Sub-population analysis

  Neurogenic injury, n = 1246

   ET (n = 579)

1.6 / 9.5 / 88.9

21(16–28)

19(15–17)

8(5–12)

5(3–6)

3(1–7)

   IMT (n = 475)

0.4 / 11.2 / 88.4

28(21–37)

26(20–35)

14(11–21)

10(8–11)

4(1–11)

   LT (n = 192)

1.6 / 13 / 85.4

40(29–57)

25(18–38)

25(18–38)

17(15–21)

7(2–15)

  Trauma, n = 308

   ET (n = 148)

0.7 / 7.4 / 91.9

22(17–32)

21(15–31)

8(6–12)

5(4–6)

3(1–6.75)

   IMT (n = 126)

1.6 / 23.8 / 74.6

27(21–40)

27(19–40)

16(11–21)

9(8–11)

4.5(2–11)

   LT (n = 34)

8.8 / 14.7 / 76.5

40(31–56)

40(30–56)

28(19–40.5)

18.75(15–22.5)

6.5(2–20)

  Respiratory disease, n = 85

   ET (n = 20)

5.0 / 45 / 50

30.5(13–48.5)

26(13–48)

14(6–30)

4(2–6)

9.5(3–23)

   IMT (n = 26)

11.5 / 30.8 / 57.7

44.5(31–60)

41(23–51)

22.5(16.5–41)

12(9–13)

11.5(5–29.5)

   LT (n = 39)

17.9 / 20.5 / 61.5

56(36–81)

50(33–73)

31(22–51)

19(16–26)

11(5–29)

  Cardiovascular disease, n = 51

   ET (n = 26)

0 / 26.9 / 73.1

24(18–35)

21(16.5–28)

9.5(7–22)

5(4–7)

4.5(2–15)

   IMT (n = 13)

7.7 / 7.7 / 84.6

49(25–58)

28(23–57)

18(12.5–33)

9(9–12)

12(1–22.5)

   LT (n = 12)

16.7 / 8.3 / 75

54.5(43.5–73)

44(35–58)

36(23–48)

17.5(13–26.5)

13.5(10–22.5)

  Coma, n = 28

   ET (n = 15)

0 / 13.3 / 86.7

29(18–34)

29(18–34)

8(5–13)

5(3–6)

3(1–7)

   IMT (n = 8)

0 / 25 / 75

42.5(38–68)

42.5(38–66)

31.5(15.5–37)

10(9–11)

20.5(5–26)

   LT (n = 5)

0 / 20 / 80

56(39–79.5)

56(39–79)

35(23.5–58)

16(14–28)

14(5–37)

  Neuromuscular disease, n = 33

   ET (n = 7)

0 / 28.6 / 71.4

27(13–51)

27(10–51)

10(6–34)

5(4–6)

5(2–30)

   IMT (n = 15)

0 / 20 / 80

50(35–59)

50(26–58)

25(18–53)

11(10–12)

14(6–41)

   LT (n = 11)

9.1 / 18.2 / 72.7

71(64–82)

67(53–81)

53(32–71)

21(18–27)

21(14–41)

  Digestive disorder, n = 53

   ET (n = 9)

0 / 33.3 / 66.7

28(20–39.5)

23(15.5–27.5)

14(6.5–16)

6(3–6)

9(1–10.5)

   IMT (n = 19)

15.8 / 26.3 / 57.9

30(22–45)

25(21–41)

20(13–26)

9(8–12)

10(2–16)

   LT (n = 25)

24 / 24 / 52

51(40.5–79.5)

43(32–73)

32(24.5–44.5)

18(15.5–23)

13(5–20)

  Others, n = 80

   ET (n = 34)

2.9 / 2.9 / 94.1

29.5(19–41)

23.5(17.5–35)

6(4–10)

4(1–5)

2(1–5)

   IMT (n = 28)

0 / 14.3 / 85.7

35.5(27–57.5)

30(21–52)

18.5(11–26)

10(8–12)

7.5(1–15)

   LT (n = 18)

5.6 / 27.8 / 66.7

52.5(38–66)

44.5(36.5–64)

34.5(25–38)

21.5(18.5–27.5)

9.5(3–20.5)